The global cancer immunotherapy market size is likely to
reach USD 126.9 billion by 2026, according to a new report by Grand View
Research, Inc., exhibiting a CAGR of 9.6% during the forecast period.
Increasing patient pool and higher mortality rate are augmenting the need for
cancer immunotherapy globally. Furthermore, increasing number of approvals for
new immunotherapeutic drugs is driving the global market.
Cancer immunotherapy has emerged as a
new avenue for revenue generation for pharmaceutical companies. In addition,
adverse effects, such as recurrence of cancer and organ failure, associated
with conventional chemotherapies and rising demand for technologically advanced
healthcare solutions are boosting the demand for immunotherapies. Moreover,
introduction of newer drug classes, such as target receptors for multiple
myeloma and checkpoint inhibitors, is poised to make way for advanced
therapeutics in the market.
Introduction of new molecules has been
proving to be beneficial for patients who are not responding to chemotherapy.
Several new immunotherapeutic options, such as immunomodulators and CAR-T cell
therapy, are in the pipeline and are being tested for their ability to provide
better cancer treatment.
Monoclonal antibodies are the most
widely used immunotherapeutic drugs globally. Development of monoclonal
antibodies as effective immunotherapeutic options started after the approval of
Blincyto (blinatumomab) by Amgen, a bispecific antibody that targets B-cell
lymphoblastic leukemia. Increasing R&D pertaining to the use of monoclonal
bodies as naked antigen binding antibodies, conjugated, and bispecific
antibodies is resulting in discovery of new therapeutic options for cancer
treatment.
Browse full research report on Cancer Immunotherapy Market: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market
Further key findings from the report suggest:
- Majority of immunotherapy drugs are being used in treatment
of cancer of lung, breast, and prostate
- Monoclonal antibodies emerged as the largest segment because
of increasing regulatory approvals and higher efficacy
- Lung cancer accounted for the largest share in 2018 and will
continue to dominate the market through 2025
- North America was the leading revenue contributor in the
market in 2018. Rising incidence of cancer and increasing demand for novel
technologies are facilitating the dominance of the region during the
forecast period
- Europe is projected to witness rapid growth during the
forecast period owing to rapid adoption of advanced cancer therapeutics
for effective treatment
- Some of the key players are Amgen, Inc.; AstraZeneca; F. Hoffmann
La Roche Ltd.; Bayer AG; Bristol-Myers Squibb Company; Eli Lilly and
Company; Merck and Co., Inc.; Novartis AG; and Pfizer, Inc.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market/request/rs1
Grand View Research has segmented the global cancer immunotherapy
market based on product, cancer type, and region:
Cancer Immunotherapy Product Outlook (Revenue, USD Billion, 2015 -
2026)
- Monoclonal
Antibodies
- Immunomodulators
- Oncolytic
Viral Therapies and Cancer Vaccines
Cancer Immunotherapy Cancer Type Outlook (Revenue, USD Billion,
2015 - 2026)
- Lung
Cancer
- Breast
Cancer
- Colorectal
Cancer
- Melanoma
- Prostate
Cancer
- Head
and Neck Cancer
- Ovarian
Cancer
- Pancreatic
Cancer
Cancer Immunotherapy Regional Outlook (Revenue, USD Billion, 2015
- 2026)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia
Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Latin
America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle
East & Africa
- South
Africa
- Saudi
Arabia
- U.A.E.
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment